A Phase IIb trial of PXT864 for Alzheimer's Disease

Trial Profile

A Phase IIb trial of PXT864 for Alzheimer's Disease

Phase of Trial: Phase II

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Acamprosate/baclofen (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2017 According to a Pharnext media release, this company expects to launch this trial in 2017.
    • 04 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top